News & Events about Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Reports Progress and Provides Recent Corporate Highlights Fusion Pharmaceuticals Reports Progress and Provides Recent Corporate Highlights PR Newswire HAMILTON, ON and BOSTON, Jan. 6, 2023 FPI-2068 IND expected to be submitted in the first quarter of 2023 FPI-1434 Phase 1...
CNW Group - News Releases
22days ago
Fusion Pharmaceuticals Reports Progress and Provides Recent Corporate Highlights Fusion Pharmaceuticals Reports Progress and Provides Recent Corporate Highlights Canada NewsWire HAMILTON, ON and BOSTON, Jan. 6, 2023 FPI-2068 IND expected to be submitted in the first quarter of 2023 FPI-1434 Phase 1...
SVB Leerink began coverage on shares of Fusion Pharmaceuticals (NASDAQ:FUSN Get Rating) in a research note issued to investors on Wednesday, MarketBeat reports. The firm issued an outperform rating and a $6.00 price objective on the stock. SVB Leerink also issued estimates for Fusion Pharmaceuticals...
Thinking about buying stock in Store Capital, AMTD Idea Group, Phunware, Fusion Pharmaceuticals, or Aditxt? Thinking about buying stock in Store Capital, AMTD Idea Group, Phunware, Fusion Pharmaceuticals, or Aditxt? PR Newswire NEW YORK, Sept. 15, 2022 NEW YORK, Sept. 15, 2022 /PRNewswire...
CNW Group - News Releases
4 months ago
Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Canada NewsWire HAMILTON, ON and BOSTON, Sept. 7, 2022 HAMILTON, ON and BOSTON, Sept. 7, 2022 /CNW...